Subhash Padhye相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin

天然化合物白花丹素衍生的 HSP40/J 结构域蛋白的新型抑制剂可消除突变型 p53

doi:10.3390/cancers14174187

Mohamed Alalem, Mrinalini Bhosale, Atul Ranjan, Satomi Yamamoto, Atsushi Kaida, Shigeto Nishikawa, Alejandro Parrales, Sana Farooki, Shrikant Anant, Subhash Padhye, Tomoo Iwakuma

发表日期：2022

文献求助收藏

Development and Characterization of an In Vitro Model for Radiation-Induced Fibrosis

放射诱导纤维化体外模型的开发和表征

期刊:Radiation Research

影响因子:2.5

doi:10.1667/RR14926.1

Dhruv Kumar, Sreeya Yalamanchali, Jacob New, Sean Parsel, Natalie New, Andrew Holcomb, Sumedha Gunewardena, Ossama Tawfik, Chris Lominska, Bruce F Kimler, Shrikant Anant, Kiran Kakarala, Terance Tsue, Yelizaveta Shnayder, Kevin Sykes, Subhash Padhye, Sufi Mary Thomas

发表日期：2018

文献求助收藏

Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers

负载姜黄素二氟化类似物的叶酸共轭聚合物胶束用于治疗宫颈癌和卵巢癌

期刊:Colloids and Surfaces B-Biointerfaces

影响因子:5.4

doi:10.1016/j.colsurfb.2017.06.025

Duy Luong, Prashant Kesharwani, Hashem O Alsaab, Samaresh Sau, Subhash Padhye, Fazlul H Sarkar, Arun K Iyer

发表日期：2017

文献求助收藏

DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway

DNAJA1 通过甲羟戊酸途径控制错误折叠突变 p53 的命运

期刊:Nature Cell Biology

影响因子:17.3

doi:10.1038/ncb3427

Alejandro Parrales, Atul Ranjan, Swathi V Iyer, Subhash Padhye, Scott J Weir, Anuradha Roy, Tomoo Iwakuma

发表日期：2016

文献求助收藏

4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells

4-(E)-{(对甲苯基亚氨基)-甲基苯-1,2-二醇}，1 一种新型白藜芦醇类似物，可差异调节乳腺癌细胞中的雌激素受体 α 和 β

期刊:Toxicology and Applied Pharmacology

影响因子:3.3

doi:10.1016/j.taap.2016.03.003

Amruta Ronghe, Anwesha Chatterjee, Bhupendra Singh, Prasad Dandawate, Fatma Abdalla, Nimee K Bhat, Subhash Padhye, Hari K Bhat

发表日期：2016

文献求助收藏

Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis

小分子MS-444抑制HuR对结直肠癌细胞肿瘤发生的影响

期刊:Oncotarget

doi:10.18632/oncotarget.12189

Fernando F Blanco, Ranjan Preet, Andrea Aguado, Vikalp Vishwakarma, Laura E Stevens, Alok Vyas, Subhash Padhye, Liang Xu, Scott J Weir, Shrikant Anant, Nicole Meisner-Kober, Jonathan R Brody, Dan A Dixon

发表日期：2016

文献求助收藏

Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells

他莫昔芬与 4-(E)-{(4-羟基苯基亚氨基)-甲基苯，1,2-二醇} 和 4-(E)-{(对甲苯基亚氨基)-甲基苯-1,2-二醇}（新型阿扎瑞白藜芦醇类似物）协同作用，抑制乳腺癌细胞增殖

期刊:Oncotarget

doi:10.18632/oncotarget.10106

Amruta Ronghe, Anwesha Chatterjee, Nimee K Bhat, Subhash Padhye, Hari K Bhat

发表日期：2016

文献求助收藏

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia

靶向 HSF1 可破坏慢性淋巴细胞白血病中的 HSP90 伴侣功能

期刊:Oncotarget

doi:10.18632/oncotarget.5167

Siddhartha Ganguly, Trisha Home, Abdulraheem Yacoub, Suman Kambhampati, Huidong Shi, Prasad Dandawate, Subhash Padhye, Ashok K Saluja, Joseph McGuirk, Rekha Rao

细胞生物学

发表日期：2015

文献求助收藏

Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog

4-(E)-{(4-羟基苯基亚氨基)-甲基苯，1,2-二醇}（一种新型白藜芦醇类似物）对雌激素受体 α 和 β 的差异调节

期刊:Journal of Steroid Biochemistry and Molecular Biology

影响因子:2.7

doi:10.1016/j.jsbmb.2014.09.015

Amruta Ronghe, Anwesha Chatterjee, Bhupendra Singh, Prasad Dandawate, Leigh Murphy, Nimee K Bhat, Subhash Padhye, Hari K Bhat

发表日期：2014

文献求助收藏

Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer

靶向 CD44 受体的异硫氰酸酯类似物是治疗结肠癌的有效策略

期刊:Medicinal Chemistry Research

影响因子:2.6

doi:10.1007/s00044-014-0958-4

Suniti Misra, Shibnath Ghatak, Alok Vyas, Paul O'Brien, Roger R Markwald, Madhukar Khetmalas, Vincent C Hascall, James B McCarthy, Nikos K Karamanos, Markku I Tammi, Raija H Tammi, Glenn D Prestwitch, Subhash Padhye

发表日期：2014

文献求助收藏